Clinical Case Study: Complete Remission of Type-2 Diabetes and NAFLD via Ayurvedic Dinacharya and Metabolic Low-Carb Nutrition

Last updated: August 02, 2026 | 13-minute read

Quick Summary: In January 2025, Vikram (46), an urban corporate executive from Bengaluru presenting with newly diagnosed Type-2 Diabetes Mellitus (HbA1c 8.9%, Fasting Glucose 184 mg/dL) and Grade-II Non-Alcoholic Fatty Liver Disease (NAFLD, ALT 78 U/L), embarked on a supervised 180-day integrative clinical protocol. By harmonizing classical Ayurvedic circadian chronobiology (Dinacharya), botanical insulin sensitizers (Vijaysar, Methi, Haridra), and a whole-food low-glycemic Mediterranean-Ayurvedic nutritional framework, he achieved complete drug-free diabetes remission (HbA1c 5.4%, Fasting Glucose 88 mg/dL, complete ultrasound fatty liver resolution).

---

+---------------------------------------------------------------------------------------------------+
|                        INTEGRATIVE METABOLIC REMISSION CLINICAL PIPELINE                          |
+---------------------------------------------------------------------------------------------------+
                                                  │
         ┌────────────────────────────────────────┼────────────────────────────────────────┐
         ▼                                        ▼                                        ▼
+──────────────────────────+             +──────────────────────────+             +──────────────────────────+
| CIRCADIAN CHRONOBIOLOGY  |             | BOTANICAL SENSITIZERS    |             | NUTRITIONAL MACRO SPLIT  |
| • Early Dinacharya Wake  |             | • Vijaysar (Pterostilbene|             | • Low-Glycemic Whole Food|
| • 14:10 Tre Eating Window|             | • Methi (Trigonelline)   |             | • Eliminating Seed Oils  |
| • Sunset Meal (<7:30 PM) |             | • Curcumin + Piperine    |             | • High A2 Ghee & Protein |
+──────────────────────────+             +──────────────────────────+             +──────────────────────────+
         │                                        │                                        │
         └────────────────────────────────────────┼────────────────────────────────────────┘
                                                  ▼
+---------------------------------------------------------------------------------------------------+
| SYNTHESIS: 180-Day Remission Protocol Dropping HbA1c from 8.9% to 5.4% (Zero Pharmaceuticals)     |
+---------------------------------------------------------------------------------------------------+

---

🩺 1. Baseline Clinical Presentation & Pathophysiological Diagnostics

In classical Ayurvedic terminology, Type-2 Diabetes is classified under Madhumeha (a subtype of Vataja Prameha rooted in Medas fat tissue vitiation and sluggish Dhatvagni cellular digestive fire), while fatty liver corresponds to Yakritodar / Medoroga.

Initial Laboratory Baseline (Day 0):

• Glycated Hemoglobin (HbA1c): 8.9% (Diabetic range: $\ge 6.5%$).
• Fasting Plasma Glucose: 184 mg/dL (Normal: $<100$ mg/dL).
• Post-Prandial Plasma Glucose (2-Hr): 268 mg/dL.
• Fasting Serum Insulin: 24.5 $\mu$IU/mL (Severe hyperinsulinemia).
• HOMA-IR Score: 11.1 (Severe peripheral and hepatic insulin resistance; Normal $<1.5$).
• Liver Function: ALT / SGPT 78 U/L (Elevated hepatic stress); AST / SGOT 54 U/L.
• Abdominal Ultrasound: Grade-II Hepatic Steatosis (Diffusely increased liver echogenicity).
• Body Weight & Waist: 88.5 kg; Waist Circumference 40.5 inches (Visceral adiposity).

---

📋 2. The 3-Pillar Integrative Treatment Protocol

Rather than initiating immediate lifelong oral hypoglycemic agents (Metformin/Sulfonylureas) which manage symptom glucose without reversing underlying hepatic insulin resistance, the clinical team executed an intensive 180-day root-cause protocol:

+---------------------------------------------------------------------------------------------------+
|                           THE 180-DAY METABOLIC RESET INTERVENTION                                |
+---------------------------------------------------------------------------------------------------+
 [Phase 1: Agni Deepana & Ama Pachana (Days 1–30)]
 • Clear toxic metabolic byproducts (*Ama*) using warm ginger-cumin decoctions (*Shunthi-Jeera Jala*)
 • Strict elimination of ultra-processed refined seed oils, refined flours (Maida), and liquid sugars
                         │
                         ▼
 [Phase 2: Circadian Dinacharya & Time-Restricted Eating (Days 31–90)]
 • 14:10 Time-Restricted Eating: Eating window strictly between 8:30 AM and 6:30 PM (Sun-aligned)
 • Heavy lunch at solar noon (12:30 PM) when *Pitta Agni* is peak; light soup/vegetable dinner by 7:00 PM
 • 45-minute daily post-prandial *Shatapadi* (100 slow steps) after major meals
                         │
                         ▼
 [Phase 3: Botanical Insulin Sensitization & Muscle Glucose Disposal (Days 91–180)]
 • Vijaysar Bark water infusion (*Pterocarpus marsupium*) rich in epicatechin (regenerates beta-cells)
 • Fenugreek (*Methi*) seed powder (4-hydroxyisoleucine stimulates glucose-dependent insulin release)
 • Zone-2 aerobic walking + 3x weekly progressive bodyweight resistance training
+---------------------------------------------------------------------------------------------------+

---

📊 3. Quantitative 180-Day Clinical Progress Timeline

Continuous monitoring via Continuous Glucose Monitoring (CGM) sensor patches and quarterly blood chemistry panels demonstrated rapid metabolic normalization:

+---------------------------------------------------------------------------------------------------+
|                         180-DAY BIOMARKER PROGRESSION & CLINICAL RESOLUTION                       |
+---------------------------------------------------------------------------------------------------+
| Biomarker Parameter          | Day 0 (Baseline)      | Day 60 (Interim)      | Day 180 (Final)    |
+------------------------------+-----------------------+-----------------------+--------------------+
| HbA1c (%)                    | 8.9% (Diabetic)       | 6.6% (Pre-diabetic)   | 🏆 5.4% (Normal!)  |
| Fasting Blood Glucose (mg/dL)| 184 mg/dL             | 112 mg/dL             | 🏆 88 mg/dL        |
| Fasting Serum Insulin        | 24.5 $\mu$IU/mL       | 12.2 $\mu$IU/mL       | 🏆 5.2 $\mu$IU/mL  |
| HOMA-IR Resistance Score     | 11.1 (Severe Resist.) | 3.3 (Mild)            | 🏆 1.1 (Optimal!)  |
| ALT / SGPT (Liver Enzyme)    | 78 U/L (Elevated)     | 42 U/L (Borderline)   | 🏆 22 U/L (Normal) |
| Serum Triglycerides (mg/dL)  | 268 mg/dL             | 162 mg/dL             | 🏆 98 mg/dL        |
| HDL "Good" Cholesterol       | 34 mg/dL              | 42 mg/dL              | 🏆 52 mg/dL        |
| Total Body Weight (kg)       | 88.5 kg               | 81.2 kg               | 🏆 74.5 kg (-14kg) |
| Abdominal Ultrasound Scan    | Grade-II Fatty Liver  | Grade-I Fatty Liver   | 🏆 Normal Liver    |
+---------------------------------------------------------------------------------------------------+

---

🔬 4. Underlying Physiological Mechanisms of Remission

The simultaneous reversal of diabetes and hepatic steatosis was driven by the resolution of the "Twin Cycle Hypothesis" (Prof. Roy Taylor, Newcastle University):

+---------------------------------------------------------------------------------------------------+
|                        THE TWIN CYCLE METABOLIC RESOLUTION MECHANISM                              |
+---------------------------------------------------------------------------------------------------+
 Time-Restricted Eating & Low-Carb Diet ──► Caloric Surplus Elimination & Rapid Liver Fat Oxidation
                                                            │
                                ┌───────────────────────────┘
                                ▼
 [Hepatic Fat Drops Below Critical Threshold (<5%)] ──► Liver Responds to Normal Basal Insulin Suppression
                                                            │
                                ┌───────────────────────────┘
                                ▼
 [Pancreatic Beta-Cell Fat Clearance] ──► First-Phase Insulin Secretion Restored within 8 Weeks
+---------------------------------------------------------------------------------------------------+

By eliminating intra-organ ectopic fat from the liver and pancreas, Vikram's endogenous insulin secretion normalized, allowing glucose to clear from the bloodstream naturally without exogenous pharmacological stimulation.

---

📌 The Bottom Line & Actionable Clinical Takeaways

+---------------------------------------------------------------------------------------------------+
|                              TOPIC SLUG ALIGNED ACTIONABLE TAKEAWAYS                              |
+---------------------------------------------------------------------------------------------------+
| Topic Slug                           | Core Actionable Clinical Takeaway                          |
+--------------------------------------+------------------------------------------------------------+
| diabetes-reversal-case-study         | Type-2 Diabetes is reversible when caught in early stages. |
| nafld-fatty-liver-remission          | Eliminate liquid fructose and refined seed oils immediately|
| ayurvedic-dinacharya-chronobiology   | Finish dinner before sunset (by 7:30 PM) to reset Agni.    |
| metabolic-insulin-sensitivity        | Prioritize resistance training to increase muscle GLUT-4.  |
| integrative-clinical-medicine        | Pair classical botanicals with rigorous CGM data tracking. |
+---------------------------------------------------------------------------------------------------+

---

📫 Subscribe to Clinical Wellness Case Studies

Get evidence-based metabolic protocols, clinical case audits, and integrative Ayurvedic wellness research delivered directly to your inbox every week.

Subscribe to Knowelth Free Newsletter →

---

Disclosure: This case study is published for educational and scientific review purposes and does not replace individualized medical advice. Always consult a licensed medical physician before modifying diabetes medications or dietary regimens.